Literature DB >> 7506084

Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture.

F Hirayama1, N Katayama, S Neben, D Donaldson, E B Nickbarg, S C Clark, M Ogawa.   

Abstract

We have investigated the effects of interleukin (IL)-12 (natural killer cell stimulatory factor/cytotoxic lymphocyte maturation factor) on the proliferation of murine myeloid and lymphohematopoietic progenitors in methylcellulose culture. In the presence of erythropoietin (Ep), IL-12 alone failed to support colony formation by mononuclear and enriched marrow cells of normal mice. Steel factor (SF) alone supported primarily formation of granulocyte/macrophage (GM) colony formation. However, the combination of the two cytokines yielded a significant number of multilineage colonies. When tested on marrow cells from 5-fluorouracil (5-FU)-treated mice, the combination of IL-12 and SF, but not the single factors, was effective in support of formation of various types of colonies. Approximately 25% of these colonies yielded pre-B-cell colonies when replated in secondary culture containing SF and IL-7, indicating that IL-12 can interact with SF in supporting the development of primitive lymphohematopoietic progenitors. These results demonstrate that IL-12, a cytokine believed to be involved in the development of cell-mediated immune responses, has a wider range of activity, including committed myeloid and multipotent lymphohematopoietic progenitors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506084

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  B lymphopoiesis: global factors, local control.

Authors:  P W Kincade
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

2.  Role of interferon-gamma in interleukin 12-induced pathology in mice.

Authors:  B D Car; V M Eng; B Schnyder; M LeHir; A N Shakhov; G Woerly; S Huang; M Aguet; T D Anderson; B Ryffel
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

3.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

4.  HemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primates.

Authors:  Lena A Basile; Dolph Ellefson; Zoya Gluzman-Poltorak; Katiana Junes-Gill; Vernon Mar; Sarita Mendonca; Joseph D Miller; Jamie Tom; Alice Trinh; Timothy K Gallaher
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

5.  Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.

Authors:  I M Bennett; O Zatsepina; L Zamai; L Azzoni; T Mikheeva; B Perussia
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

6.  Distinguishing autocrine and paracrine signals in hematopoietic stem cell culture using a biofunctional microcavity platform.

Authors:  Eike Müller; Weijia Wang; Wenlian Qiao; Martin Bornhäuser; Peter W Zandstra; Carsten Werner; Tilo Pompe
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

7.  Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells.

Authors:  Shanshan Zhang; Maiko Morita; Zhao Wang; Jun Ooehara; Sen Zhang; Miner Xie; Haitao Bai; Wenying Yu; Xiaofang Wang; Fang Dong; Jinhong Wang; Shihui Ma; Satoshi Yamazaki; Hideo Ema
Journal:  Blood Sci       Date:  2019-09-17

8.  The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo.

Authors:  V M Eng; B D Car; B Schnyder; M Lorenz; S Lugli; M Aguet; T D Anderson; B Ryffel; V F Quesniaux
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

9.  Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects.

Authors:  Mamata S Gokhale; Vladimir Vainstein; Jamie Tom; Simmy Thomas; Chris E Lawrence; Zoya Gluzman-Poltorak; Nicholas Siebers; Lena A Basile
Journal:  Exp Hematol Oncol       Date:  2014-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.